Insulin icodec, which will be sold under the brand name Awiqli, is shown in a handout photo. .Many people with diabetes in Canada will soon be able to take insulin once a week instead of daily, drug manufacturer Novo Nordisk announced on Monday.
“ huge for reducing the burden on these people who need to inject insulin,” said Bajaj, an endocrinologist at LMC, a publicly-funded diabetes and endocrinology specialty clinic with locations across southern Ontario and in Calgary. People with Type 2 diabetes do make insulin, but either not enough or their bodies don’t use it properly. Basal insulin shots bring their levels of the hormone to the right amount during fasting, and other medications can control the “spikes of sugars that come with food,” Bajaj said.
“The impact for patients is that less of them will be left with high blood sugar for longer,” Abitbol said. “It’s not going to be for every patient with diabetes, but for those that are suitable, it will likely be a better option for them than the daily basal insulin.” “It can be a good option because it gives you one needle a week rather than a needle every day,” Ur said in an interview.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CTVNews - 🏆 1. / 99 Read more »